Robbi M, Beaufay H
Laboratorie de Chimie Physiologique, Université de Louvain, Brussels, Belgium.
Biochem J. 1988 Aug 15;254(1):51-7. doi: 10.1042/bj2540051.
Rat liver pI-6.4 esterase was purified from microsomes (microsomal extracts) and used to generate antibodies in the rabbit. Two active enzyme forms, similarly sensitive to endo-H (endo-beta-N-acetylglucosaminidase H (EC 3.2.1.96), but differing slightly in polypeptide chain length, were present in the preparation. In microsomes, immunoblots revealed a single form, with Mr congruent to 62,000, identical with the large component of the purified enzyme, indicating that the second component is an artefact. Rabbit reticulocyte lysates and wheat germ extracts programmed with RNA extracted from total or bound polysomes synthesized a single immunoreactive 61 kDa polypeptide, which was not formed with RNA extracted from free polysomes. The immunoreactive product synthesized in the presence of dog pancreas microsomes was slightly larger (62 kDa); like the authentic enzyme, it bound to concanavalin A and was decreased in molecular size to 60 kDa by the action of endo-H. Thus the enzyme is synthesized with a short cleavable sequence and bears at least one high-mannose oligosaccharide chain. Metabolic labelling in hepatocytes cultured with [35S]methionine also generated a single immunoreactive polypeptide of 62 kDa, which was decreased to 60 kDa in size by treatment with endo-H or addition of tunicamycin to the culture medium. This confirms the molecular homogeneity and the glycosylation of the enzyme in the intact cell. Culture media contained no pI-6.4-esterase-related protein, whether tunicamycin was present or not. The processing steps in the synthesis of pI-6.4 esterase are thus, as for other esterases of the endoplasmic reticulum [Robbi & Beaufay (1986) Eur. J. Biochem. 158, 187-194; (1987) Biochem. J. 248, 545-550] indistinguishable from those occurring early in the synthesis of secretory proteins. Glycosylation is apparently not the sorting signal responsible for their retention in the endoplasmic reticulum.
大鼠肝脏pI-6.4酯酶从微粒体(微粒体提取物)中纯化出来,并用于在兔体内产生抗体。制剂中存在两种活性酶形式,它们对内切-H(内切-β-N-乙酰葡糖胺糖苷酶H(EC 3.2.1.96))的敏感性相似,但多肽链长度略有不同。在微粒体中,免疫印迹显示单一形式,Mr约为62,000,与纯化酶的大分子成分相同,表明第二种成分是人为产物。用从总多核糖体或结合多核糖体提取的RNA编程的兔网织红细胞裂解物和小麦胚芽提取物合成了一种单一的免疫反应性61 kDa多肽,而用从游离多核糖体提取的RNA则不能合成。在犬胰腺微粒体存在下合成的免疫反应性产物略大(62 kDa);与天然酶一样,它与伴刀豆球蛋白A结合,并通过内切-H的作用分子大小降至60 kDa。因此,该酶是通过一个短的可切割序列合成的,并且带有至少一条高甘露糖寡糖链。在用[35S]甲硫氨酸培养的肝细胞中进行代谢标记也产生了一种单一的62 kDa免疫反应性多肽,通过用内切-H处理或向培养基中添加衣霉素,其大小降至60 kDa。这证实了完整细胞中该酶的分子同质性和糖基化。无论是否存在衣霉素,培养基中都不含有与pI-6.4酯酶相关的蛋白质。因此,pI-6.4酯酶合成中的加工步骤,与内质网的其他酯酶一样[罗比和博法伊(1986年)《欧洲生物化学杂志》158卷,187 - 194页;(1987年)《生物化学杂志》248卷,545 - 550页],与分泌蛋白合成早期发生的步骤无法区分。糖基化显然不是负责它们保留在内质网中的分选信号。